People with Parkinson's disease (PD) tend to slow down and decrease the intensity of their movements even though many retain the ability to move more quickly and forcefully. Now, in proof-of-concept experiments with "joysticks" ...
Sep 9, 2015
0
286
Two proteins that share the ability to help cells deal with their trash appear to need each other to do their jobs and when they don't connect, it appears to contribute to development of Parkinson's disease, scientists report.
Aug 20, 2015
0
167
Scientists from Singapore's Nanyang Technological University (NTU Singapore) and McLean Hospital and Harvard Medical School in the United States have found that existing anti-malaria drugs could be a potential treatment for ...
Jul 16, 2015
0
155
Why does the promise of a reward—basically any kind of fun—cause teens to hurl caution into the wind?
Jun 30, 2015
0
156
Gene therapy to reduce production of a brain protein successfully prevented development of Parkinson's disease in an animal study, according to researchers at the University of Pittsburgh School of Medicine. The findings, ...
Jun 15, 2015
0
57
Nerve cells that produce dopamine for the purpose of transmitting signals to other cells affect numerous crucial brain functions. This becomes evident in diseases such as Parkinson's and schizophrenia, where dopamine transmission ...
May 12, 2015
0
105
Dopamine is the chemical messenger in the brain most closely associated with pleasure and reward. Recent scientific advances now shed light on precise roles for dopamine in the reward process.
May 11, 2015
0
41
The decades worth of data that has been collected about the billions of neurons in the brain is astounding. To help scientists make sense of this "brain big data," researchers at Carnegie Mellon University have used data ...
Mar 30, 2015
0
66
A key factor in the motor symptoms associated with Parkinson's disease is the gradual destruction of dopamine neurons. The glial cell-derived neurotrophic factor, or GDNF, has been proven to protect dopamine neurons in test ...
Mar 4, 2015
0
10
Researchers have long sought treatments that can slow the progression of Parkinson's disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopamine, which the dying nerve ...
Feb 18, 2015
0
44
